Document is current
Any future updates will be listed below
-
Authors
Self, Wade K. https://orcid.org/0000-0003-1648-6124
Holtzman, David M. https://orcid.org/0000-0002-3400-0856
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (RF1NS090934, RF1AG047644)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (U19AG069701)
Cure Alzheimer’s Fund
JPB Foundation
- License Information
-
More Information
Article History
Received: 31 March 2023
Accepted: 18 July 2023
First Online: 4 September 2023
Competing interests
: W.K.S. declares no competing interests. D.M.H. cofounded and is on the scientific advisory board of C2N Diagnostics. D.M.H. is on the scientific advisory board of Denali, Cajal Neuroscience and Genentech and consults for Asteroid Therapeutics. D.M.H. is an inventor on a patent on APOE antibodies that was licensed by Washington University to NextCure.
